pretty interesting via Brian Dolan - a digital therapeutics company spinning out a virtual clinic I suspect as more digital therapeutics struggle to get payer + clinician adoption, this becomes a more popular go-to-market especially to get evidence

Nikhil Krishnan Brian Dolan i think this approach makes a lot more sense from a payment and value capture perspective. and for controlling the experience and making sure the DTx tools are used uniformly and effectively.

Which health tech-focused (entirely or partially) investors/VCs have worthwhile newsletters, podcasts, or blogs that are more under-the-radar than others?

Pear Therapeutics announced that they are filing for bankruptcy, which made me sad. Although my thinking has changed over time on DTx, I am still a fanboy at heart, feel pretty lucky to have seen this whole arc and feel like reminiscing. forbes.com/sites/katiejen…

Chris Hogg excellent thread - and I think your point around digital therapeutics building out full clinics is already happening (see below h/t Brian Dolan) IMO the path forward is to build out opinionated care models that target a specific disease area, which I think dTX can be great for

This report from Brian Dolan on Big Health is a must read for everyone interested in the Dtx space The most interesting part to me was that Big Health uses its clinical research programs as a moat - see a slide of their sales deck (2021):

In this week's Exits&Outcomes Friday newsletter: - Was ex-CEO the mystery buyer in Pear's asset auction? - Woebot pauses its postpartum depression prescription digital therapeutic -Swing Therapeutics gets FDA De Novo but PDT go-to-market is its own virtual clinic, Swing Care

The Spring Health Report is another banger by Exits&Outcomes (Brian Dolan). My top three favorite insights: (1) Sell then build Doesn't matter if this is your 1st product or a feature you'll spend significant time on. Make sure people want to pay (extra)

Won't spill all the beans, but you can find the complete report here: exitsandoutcomes.com/the-spring-hea… (don't forget to subscribe to Brian Dolan's blog)

Lol wut Via Exits&Outcomes

Love Exits&Outcomes. Among the best healthcare analysts around.

Rik Renard Exits&Outcomes Now you’re just straight up stealing all my best client advice. Including that they need to subscribe to Exits&Outcomes

can't recommend Brian Dolan 's exit & outcomes publication enough - the databases alone are interesting exitsandoutcomes.com/pricing-for-do…